FENC
NASDAQ · Biotechnology
Fennec Pharmaceuticals Inc
$10.83
+0.23 (+2.12%)
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+175.2% upside
Low Target
$21.84
Average Target
$29.80
High Target
$37.23
Current Price
$10.83
Current
$10.83
$10.83
Target
$29.80
$29.80
$21.84
$29.80 avg
$37.23
Scenario Analysis
Bear Case
$21.84
101.7%
Low target
Base Case
$29.80
+175.2%
Avg target
Bull Case
$37.23
+243.8%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$13.25
-18.3% from high
52-Week Low
$5.65
+91.7% from low
Target vs 52W High
$29.80
+124.9% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -3.3% |
| AMGN | Hold | 43 | 47% | $190.87 | -54.4% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +138.3% |
| VRTX | Strong Buy | 36 | 81% | $438.34 | -16.9% |
| REGN | Buy | 38 | 68% | $76.80 | -89.8% |
| MRNA | Hold | 30 | 37% | $149.45 | -24.2% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -65.3% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -43.4% |